Interventional radiologists have long suspected ionizing radiation has detrimental effects on them, including cataracts, radiodermatitis, and hand depilation.
Interventional radiologists have long suspected ionizing radiation has detrimental effects on them, including cataracts, radiodermatitis, and hand depilation. A study published in the European Journal of Radiology provides proof for those suspicions and expands the exposure risks.
The investigators found the lifetime attributable risk and the excess ratio of radio-induced cancers is appreciable for some cases and some forms of cancer, such as leukemia (Eur J Radiol 2010;75:259-264).
Of 700 workers exposed to ionizing radiation sources, six interventional radiologists from the Universitario Le Fe in Valencia, Spain, all of whom showed symptoms of radiation exposure, were selected for inclusion in the study.
The minimum average excess ratio for skin cancer using wrist physical doses is 1.03 x 10-3; the maximum is 5.06 x 10-2. The range the interventional radiologists experienced is lower than the maximum average, so they were not considered to be at increased risk for skin cancer.
The minimum average excess ratio for leukemia using thermoluminescence dosimeters is 7.84 x 10-2; the maximum is 3.36 x 10-1. Using both the thermoluminescence dosimeters and biological dosimetry, the radiologists were found to be at increased risk for leukemia.
This study reminds radiologists of the risks of working with ionizing radiation, which includes an increased risk of leukemia, said Dr. Robert Vogelzang, past president of the Society of Interventional Radiology, and a professor of radiology at Northwestern University.
“To me, I take away a simple thing,” he said. “We need to do as much as we can to reduce risk because there are statistically relevant data that show an increased risk for some cancers.”
Should interventional radiologists limit the number of any of the procedures they perform due to the risks involved? Yes and no, according to Vogelzang.
“We have so many imaging modalities, we have to always be aware of the dose we’re using and the number of exams we do,” he said. “It cannot be a ‘let’s just see what we see.’ You have to ask always and every time, ‘is this necessary?’”
The question has to be asked not only for the patient’s sake, but also for any radiation worker-the radiologist, the technologist, and the nurses standing in the rooms, he said. All are exposed to radiation.
“Awareness of that is really what this is about,” he said. “This is a big issue when it comes to worker and patient safety. It’s that simple. To the degree we see effects, [they] can be attributed to the radiation.”
Vogelzang echoed comments made by the study’s authors.
Because of the observed appreciable risk of leukemia and cancer incidence in the group of radiologists, theoretical and practical education is needed for those who go into specialties that put them at increased risk. Training for the medical staff in the cardiology/radiology and nuclear medicine departments is needed, they said.
Training in radiological protection for patients and staff should be an integral part of the education of those using interventional techniques. Risks and benefits, including detrimental effects of radiation exposure, should be taken into account when new interventional techniques are introduced, they said.
“This study is not going to prevent me from working in a radiation field, but it’s proof radiation has definable risks,” Vogelzang said.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.